Corcept Therapeutics Inc (CORT) stock
CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/30537% above fair value
$70.07+0.85 (+1.23%)
Close on Nov 17, 2026Market cap $7.57BP/E 166.8Yield –
Corcept Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Corcept Therapeutics's market cap was $8.61B on Nov 11, 2026, against $9.51B a year earlier. Over the last 5 years it ranged from $2.25B to $13.32B, with a median of $3.75B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.61B | +106.7% |
| 2025 | Dec 31, 2025 | $4.17B | -25.8% |
| 2024 | Dec 31, 2024 | $5.61B | +52.8% |
| 2023 | Dec 29, 2023 | $3.67B | +54.2% |
| 2022 | Dec 30, 2022 | $2.38B | -5.3% |
| 2021 | Dec 31, 2021 | $2.52B | -21.9% |
| 2020 | Dec 31, 2020 | $3.22B | +116.2% |
| 2019 | Dec 31, 2019 | $1.49B | -12.4% |
| 2018 | Dec 31, 2018 | $1.70B | -17.5% |
| 2017 | Dec 29, 2017 | $2.06B | +155.9% |
| 2016 | Dec 30, 2016 | $805.00M | +48.6% |
| 2015 | Dec 31, 2015 | $541.55M | +78.5% |
| 2014 | Dec 31, 2014 | $303.42M | -5.3% |
| 2013 | Dec 31, 2013 | $320.40M | +151.5% |
| 2012 | Dec 31, 2012 | $127.40M | -50.9% |
| 2011 | Jul 29, 2011 | $259.21M | – |
See a number that looks wrong?